C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/18/2004	WO2004099365A2 Transcription factor gene induced by water deficit conditions and abscisic acid from helianthus annuus, promoter and transgenic plants
11/18/2004	WO2004099287A1 Polyethylene glycol/polycation block copolymer
11/18/2004	WO2004099251A2 Compositions and methods for treatment of cryptococcosis
11/18/2004	WO2004099247A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	WO2004099244A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	WO2004099243A2 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
11/18/2004	WO2004098648A1 Gene therapy for neurometabolic disorders
11/18/2004	WO2004098647A2 Claudins’ underexpression as markers of tumor metastasis
11/18/2004	WO2004098646A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
11/18/2004	WO2004098536A2 Anti-viral activity of cathelicidin peptides
11/18/2004	WO2004098534A2 Methods for delivering angiogenic modulators using pox viruses
11/18/2004	WO2004098533A2 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	WO2004098532A2 Methods of reducing an immune response
11/18/2004	WO2004098531A2 Increased transduction using abc transporter substrates and/or inhibitors
11/18/2004	WO2004098530A2 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
11/18/2004	WO2004098526A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/18/2004	WO2004098515A2 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
11/18/2004	WO2004098508A2 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells
11/18/2004	WO2004098499A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/18/2004	WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098490A2 Mesoderm and definitive endoderm cell populations
11/18/2004	WO2004092214A3 Affinity purification system using troponin molecules as affinity ligands
11/18/2004	WO2004090133A3 Method of rna cleavage and recombination
11/18/2004	WO2004087930A8 Adenovirus replication-competent vectors expressing trail
11/18/2004	WO2004087928A3 Transgenic plants expressing a gene encoding a xyloglucan endotransglycosylase
11/18/2004	WO2004087918A3 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
11/18/2004	WO2004087861A3 Biological contamination-removal method
11/18/2004	WO2004087752A3 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders
11/18/2004	WO2004085648A3 Nogo receptor binding protein
11/18/2004	WO2004084951A3 A method and vectors for selectively transducing retinal pigment epithelium cells
11/18/2004	WO2004078097A8 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
11/18/2004	WO2004076669A3 Cysteine-substituted, fad-dependent sulfhydryl oxidases
11/18/2004	WO2004075836A9 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
11/18/2004	WO2004074841A3 Kor3l-like-proteins and methods of modulating kor3l-mediated activity
11/18/2004	WO2004074491A3 Expression in plants of antibodies against enterotoxigenic escherichia coli
11/18/2004	WO2004072116A3 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1β
11/18/2004	WO2004072115A3 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies
11/18/2004	WO2004065601A3 Lipophilic derivatives of double-stranded ribonucleic acid
11/18/2004	WO2004060476A3 Wound healing method and kits
11/18/2004	WO2004050899A3 Method for in vitro selection of 2’-substituted nucleic acids
11/18/2004	WO2004050858A3 Compositions, splice variants and methods relating to colon specific genes and proteins
11/18/2004	WO2004048562A8 PROCESSES FOR PRODUCING HUMAN-ORIGIN β1,3-N-ACETYLGLUCOSAMINYL TRANSFERASE 2
11/18/2004	WO2004046340A3 Intron fusion construct and method of using for selecting high-expressing production cell lines
11/18/2004	WO2004041854A3 Essential novel bacterial polypeptides
11/18/2004	WO2004034093A3 Caterpiller gene family
11/18/2004	WO2004027064A3 Ghrh analogues
11/18/2004	WO2004019893A3 Modulators of angiogenesis
11/18/2004	WO2004005535A3 Pathogenicity proteins which can be used as targets for developing means for preventing and controlling bacterial infections
11/18/2004	WO2004004447A3 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
11/18/2004	WO2004000164A3 Amniotic membrane mediated delivery of bioactive molecules
11/18/2004	WO2003096797A3 Method of increasing plant organ and seed size in a plant
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003090694A3 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases
11/18/2004	WO2003087021A8 Nanoparticle delivery systems and methods of use thereof
11/18/2004	WO2003084312A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato
11/18/2004	WO2003080805A3 Kinases and phosphatases
11/18/2004	WO2003076591A8 Compositions and methods for generating an immune response
11/18/2004	WO2003073067A3 Rna detection enzymes
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2003004602A3 Nuclease resistant chimeric oligonucleotides
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	WO2002068598A3 Novel selectable marker in plants and other organisms
11/18/2004	WO2001085943A9 Anergy associated genes
11/18/2004	US20040231016 Using antisense agents to reduce preferential gene expression in plants; gene expression inhibition
11/18/2004	US20040231015 Integration and expression plastid vector for stably transforming a plastid genome of a monocotyledonous or dicotyledonous plant; transfer and propagation of heterologous nucleotide sequences
11/18/2004	US20040231014 Method of producing non-human mammals
11/18/2004	US20040231013 Transgenic mouse expressing fluorescent protein for use of whole body imaging in comparative disease diagnosis and prognosis; colorimetric analysis
11/18/2004	US20040231012 Transgenic rodent comprising yeast artifical chromosome which codes immunoglobulin for use as bioreactor for propagation of human antibodies
11/18/2004	US20040231010 Lysozyme transgenic ungulates
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040231007 Assay for identifying compounds which affect stability of mRNA
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230380 Novel proteins with altered immunogenicity
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230048 High efficiency mrna isolation methods and compositions
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230042 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
11/18/2004	US20040230040 Modified growth hormone protein for use in prevention and treatment of cachexia associated with secondary effect of viral or metabolic diseases
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040230036 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection; solid phase synthesis
11/18/2004	US20040230034 Hybrid heterodimeric protein hormone and method of using same
11/18/2004	US20040230032 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229833 Therapeutic use of cis-element decays in vivo
11/18/2004	US20040229831 Compositions and methods for non-parenteral delivery of oligonucleotides
11/18/2004	US20040229829 Enzyme inhibitors for metabolic redirection
11/18/2004	US20040229828 Administering a therapeutically effective amount of at least one pharmacologically acceptable oligonucleotide at least 10 nucleotides in length
11/18/2004	US20040229827 Dna immunization vectors
11/18/2004	US20040229806 Hirulog-like peptide and gene therapy
11/18/2004	US20040229804 Tribonectins
11/18/2004	US20040229797 Protein that comprises an amino-acid in which one or several amino acids are deleted, substituted or added, and has effects of controlling cell migration and cell death in L-FILIP, S-FILIP, or other amino-acid sequence
11/18/2004	US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229783 Inhibiting an inflammatory response in a tissue comprising leptin receptor positive cells, by administering to the tissue an agent that inhibits the signaling activity of the leptin receptor that mediates intestinal inflammation, thereby inhibiting the inflammatory response in the tissue
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

1 ... 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 ... 4023